Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMLODIPINE\LOSARTAN: 23 Adverse Event Reports & Safety Profile

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy
23
Total FAERS Reports
4 (17.4%)
Deaths Reported
12
Hospitalizations
23
As Primary/Secondary Suspect
2
Life-Threatening
1
Disabilities

First Report: 20110714 · Latest Report: 20221223

What Are the Most Common AMLODIPINE\LOSARTAN Side Effects?

#1 Most Reported
Shock
6 reports (26.1%)
#2 Most Reported
Intentional overdose
4 reports (17.4%)
#3 Most Reported
Pancreatitis
3 reports (13.0%)

All AMLODIPINE\LOSARTAN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Shock 6 26.1% 2 5

Who Reports AMLODIPINE\LOSARTAN Side Effects? Age & Gender Data

Gender: 52.4% female, 47.6% male. Average age: 52.1 years. Most reports from: US. View detailed demographics →

Is AMLODIPINE\LOSARTAN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2011 3 0 2
2014 1 0 1
2015 3 3 3
2018 2 0 0
2019 1 0 1
2022 2 1 0

View full timeline →

What Is AMLODIPINE\LOSARTAN Used For?

IndicationReports
Product used for unknown indication 9
Hypertension 5

Official FDA Label for AMLODIPINE\LOSARTAN

Official prescribing information from the FDA-approved drug label.